2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1447399340
Verify on CMS →

ROBERT MAIMONE

Oral and Maxillofacial Pathology Dentistry in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
571
Medicare Part D claims · 416 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
What the federal data reveals: ROBERT MAIMONE is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 571 claims across 416 beneficiaries .

What stands out: ROBERT MAIMONE filed 571 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROBERT MAIMONE at a glance

Quality data not reported

NPI registry status

Active

Issued 02/06/2007

NPI 1447399340

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

571 88% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in New York

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among New York providers

New York providers

Oral and Maxillofacial Pathology Dentistry share within New York

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT MAIMONE is a Oral and Maxillofacial Pathology Dentistry provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1447399340. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT MAIMONE appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider at 205 E 16TH ST APT LL, NEW YORK, NY, 10003, with a listed phone of (212) 228-2505. NPI 1447399340 was issued on 02/06/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAIMONE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 571 prescription claims written by this provider, covering 416 Medicare beneficiaries and totaling roughly $3K in drug spend, with an opioid prescribing rate of 19.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

205 E 16TH ST APT LL
NEW YORK, NY 10003

Provider Details

NPI 1447399340
Specialty Oral and Maxillofacial Pathology Dentistry
Gender Male
NPI Issued 02/06/2007

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROBERT MAIMONE. To verify ROBERT MAIMONE's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

571
Total Claims
$3K
Total Drug Cost
416
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
571
Total Day Supply
4,044
Generic Drug Cost
$3K
Opioid Claims
110 (19.3% rate)
Antibiotic Claims
451

Patient Demographics

Average Patient Age
76.3 years
Avg HCC Risk Score
1.08
Gender Split
52% female / 48% male
Age Distribution
<65: 15, 65-74: 173, 75-84: 140, 85+: 88

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amoxicillin
307
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
106
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
63
Azithromycin
49
Ciprofloxacin Hcl
14
Clindamycin Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How ROBERT MAIMONE fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

ROBERT MAIMONE's 571 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MAIMONE.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT MAIMONE's specialty?
ROBERT MAIMONE specializes in Oral and Maxillofacial Pathology Dentistry and practices in NEW YORK, New York.
How much does ROBERT MAIMONE prescribe under Medicare Part D?
In 2023, ROBERT MAIMONE wrote 571 Medicare Part D claims totaling $3K in drug costs for 416 beneficiaries.
Where is ROBERT MAIMONE located?
ROBERT MAIMONE is located at 205 E 16TH ST APT LL, NEW YORK, NY, 10003. Phone: (212) 228-2505.
What is ROBERT MAIMONE's NPI number?
ROBERT MAIMONE's National Provider Identifier (NPI) is 1447399340, issued on 02/06/2007.
Does ROBERT MAIMONE prescribe opioids?
Yes, ROBERT MAIMONE had 110 opioid claims in 2023 with an opioid prescribing rate of 19.3%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does ROBERT MAIMONE prescribe most often?
Based on 2023 Medicare Part D data, ROBERT MAIMONE's most frequently prescribed drugs include Amoxicillin, Hydrocodone-Acetaminophen, Amoxicillin-Clavulanate Potass. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT MAIMONE accept Medicare?
ROBERT MAIMONE appears in CMS Medicare data with 571 Part D claims and 416 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT MAIMONE's credentials?
ROBERT MAIMONE's NPI is 1447399340. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology